Choose your Region

Are you sure you want to proceed?

You will be leaving the Cook Medical website that you were viewing and going to a Cook Medical website for another region or country. Not all products are approved in all regulatory jurisdictions. The product information on these websites is intended only for licensed physicians and healthcare professionals.

November 20th, 2020

Zilver® Vena™ Venous Self-Expanding Stent available in US

Bloomington, Ind. – Cook Medical today announced that the Zilver® Vena Venous Self-Expanding Stent is commercially available to physicians in the United States.

Zilver Vena is a self-expanding stent designed to meet the needs of patients suffering from symptomatic iliofemoral venous outflow obstruction. When implanted in a patient, the stent expands to keep blood flowing through narrow or blocked iliofemoral veins. The stent was designed to balance flexibility and strength: it’s flexible so that it can conform to a patient’s anatomy while it provides sufficient lumen expansion to restore venous flow.

Since Zilver Vena received FDA approval to treat patients suffering from iliofemoral venous disease, Cook will soon begin launching physician training and other support programs to go along with the product.

“Cook Medical is proud to offer the Zilver Vena stent to physicians,” said Mark Breedlove, vice president of Cook Medical’s Vascular division. “Cook continues to drive innovation for venous therapies. Along with this stent, we are offering medical education training programs and building clinical evidence so that we can better understand venous disease.”

Physician trainings for Zilver Vena will be available soon. To learn more, visit the Zilver Vena product page here.

About Cook Medical
Since 1963, Cook Medical has been inventing, manufacturing and delivering a unique portfolio of medical devices to healthcare systems around the world. We work closely with physicians to develop technologies that improve patients’ lives. Because we remain family owned, we have the freedom to focus on what we care about: patients, our employees and our communities. Find out more at, and for the latest news, follow us on TwitterFacebook and LinkedIn.